HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
Holdings, Q1 2025
Positions as of Mar 31, 2025, filed May 15, 2025.SEC
- Positions
- 49
- +4 vs. Q4 2024
- Total value
- $3.54B
- +$652.21M (+22.6%) vs. Q4 2024
Compare with Q4 2024: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q4 2024.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| PDDPDD HOLDINGS INC | SPONSORED ADS | 6,562,576 | $776.68M | 21.94% | +3,832,301+140.4% | Added | View |
| BABAALIBABA GROUP HLDG LTD SPONSORED ADS | ADR | 3,907,755 | $516.72M | 14.60% | −979,545−20.0% | Reduced | View |
| FUTUFUTU HLDGS LTD | SPON ADS CL A | 4,307,492 | $440.87M | 12.46% | +3,189,189+285.2% | Added | View |
| ONCBEONE MEDICINES LTD SPONSORED ADS | ADR | 1,034,306 | $281.51M | 7.95% | −2,770,100−72.8% | Reduced | View |
| NTESNETEASE COM INC | SPONSORED ADS | 2,668,697 | $274.66M | 7.76% | +79,754+3.1% | Added | View |
| BEKEKE HLDGS INC | SPONSORED ADS | 11,973,402 | $240.55M | 6.80% | +712,126+6.3% | Added | View |
| LEGNLEGEND BIOTECH CORP | SPONSORED ADS | 5,984,550 | $203.06M | 5.74% | 00.0% | Unchanged | View |
| JDJD.COM INC | SPON ADS CL A | 4,811,700 | $197.86M | 5.59% | +3,121,700+184.7% | Added | View |
| VIPSVIPSHOP HLDGS LTD | SPONSORED ADS A | 6,683,901 | $104.8M | 2.96% | −8,196,101−55.1% | Reduced | View |
| WNS HLDGS LTDG98196101 | COM SHS | 1,531,466 | $94.17M | 2.66% | 00.0% | Unchanged | – |
| AVBPARRIVENT BIOPHARMA INC | COM | 4,484,672 | $82.92M | 2.34% | 00.0% | Unchanged | View |
| TCOMTRIP COM GROUP LTD | ADS | 938,842 | $59.69M | 1.69% | +25,000+2.7% | Added | View |
| ENFUSION INC292812104 | CL A | 4,975,183 | $55.47M | 1.57% | 00.0% | Unchanged | – |
| YSGYATSEN HLDG LTD | SPONSORED ADS | 6,885,873 | $33.12M | 0.94% | 00.0% | Unchanged | View |
| CTKBCYTEK BIOSCIENCES INC | COM | 6,657,030 | $26.69M | 0.75% | 00.0% | Unchanged | View |
| BIDUBAIDU INC SPON ADR REP A | ADR | 170,000 | $15.65M | 0.44% | +170,000 | New | View |
| LILI AUTO INC | SPONSORED ADS | 620,000 | $15.62M | 0.44% | +620,000 | New | View |
| YUMCYUM CHINA HLDGS INC | COM | 292,122 | $15.21M | 0.43% | +292,122 | New | View |
| ZTOZTO EXPRESS CAYMAN INC | SPONSORED ADS A | 671,387 | $13.32M | 0.38% | +235,460+54.0% | Added | View |
| BZKANZHUN LIMITED | SPONSORED ADS | 576,339 | $11.05M | 0.31% | +576,339 | New | View |
| HTHTH WORLD GROUP LTD | SPONSORED ADS | 237,332 | $8.78M | 0.25% | +237,332 | New | View |
| APIAGORA INC | ADS | 2,098,553 | $8.44M | 0.24% | 00.0% | Unchanged | View |
| ATATATOUR LIFESTYLE HLDGS LTD | SPONSORED ADS | 242,342 | $6.87M | 0.19% | +242,342 | New | View |
| TSMTAIWAN SEMICONDUCTOR MANUFACT SPONSORED ADS | ADR | 33,000 | $5.48M | 0.15% | −9,588−22.5% | Reduced | View |
| GOSSGOSSAMER BIO INC | COM | 4,974,041 | $5.47M | 0.15% | 00.0% | Unchanged | View |
| MAZEMAZE THERAPEUTICS INC | COM | 457,535 | $5.04M | 0.14% | +457,535 | New | View |
| NBPNOVABRIDGE BIOSCIENCES | SPONSORED ADS | 5,980,568 | $4.93M | 0.14% | 00.0% | Unchanged | View |
| TUYATUYA INC | SPONSERED ADS | 1,564,400 | $4.74M | 0.13% | 00.0% | Unchanged | View |
| CTNMCONTINEUM THERAPEUTICS INC | CL A | 669,337 | $4.67M | 0.13% | 00.0% | Unchanged | View |
| SMART SH GLOBAL LTD ADS83193E102 | ADR | 3,949,700 | $4.42M | 0.12% | 00.0% | Unchanged | – |
| SOHUSOHU COM LTD | SPONSORED ADS | 201,432 | $2.65M | 0.07% | −309,052−60.5% | Reduced | View |
| SGMTSAGIMET BIOSCIENCES INC | COM SER A | 724,800 | $2.36M | 0.07% | 00.0% | Unchanged | View |
| MOGUMOGU INC | SPON ADS | 847,510 | $1.87M | 0.05% | 00.0% | Unchanged | View |
| BRIGHT SCHOLAR ED HLDGS LTD109199208 | SPON ADS NEW | 988,143 | $1.65M | 0.05% | 00.0% | Unchanged | – |
| DHRDANAHER CORP DEL COM | Stock | 8,026 | $1.65M | 0.05% | −5,053−38.6% | Reduced | View |
| JOYYJOYY INC | ADS REPSTG COM A | 34,000 | $1.43M | 0.04% | +4,000+13.3% | Added | View |
| GEGE AEROSPACE COM NEW | Stock | 6,757 | $1.35M | 0.04% | −3,571−34.6% | Reduced | View |
| MCOMOODYS CORP COM | Stock | 2,637 | $1.23M | 0.03% | −1,840−41.1% | Reduced | View |
| MSCIMSCI INC COM | Stock | 2,128 | $1.2M | 0.03% | −1,522−41.7% | Reduced | View |
| CYDCHINA YUCHAI INTL LTD | COM | 70,000 | $1.19M | 0.03% | +70,000 | New | View |
| PACBPACIFIC BIOSCIENCES CALIF IN | COM | 918,892 | $1.08M | 0.03% | 00.0% | Unchanged | View |
| WBWEIBO CORP | SPONSORED ADR | 100,000 | $947K | 0.03% | +100,000 | New | View |
| XYFX FINL | SPONSORED ADS | 50,000 | $719.5K | 0.02% | +50,000 | New | View |
| ALGSALIGOS THERAPEUTICS INC | COM NEW | 76,247 | $629.04K | 0.02% | 00.0% | Unchanged | View |
| ECXECARX HOLDINGS INC | CLASS A ORD | 400,000 | $504K | 0.01% | +400,000 | New | View |
| MGXMETAGENOMI THERAPEUTICS INC | COM | 150,699 | $204.95K | 0.01% | −627,069−80.6% | Reduced | View |
| LAKESHORE BIOPHARMA CO LTDG9845F208 | ORD SHS NEW | 75,179 | $181.93K | 0.01% | 00.0% | Unchanged | – |
| UXINUXIN LTD | SPONSORED ADS | 19,156 | $76.43K | 0.00% | 00.0% | Unchanged | View |
| RDGTCHINA JO-JO DRUGSTORES INC | SHS NEW | 20,167 | $21.18K | 0.00% | 00.0% | Unchanged | View |
Sold out since Q4 2024 (7)
Positions held at the end of Q4 2024 that are no longer in this filing.
| Security | Class | Shares, Q4 2024 | Value, Q4 2024 | % of portfolio, Q4 2024 |
|---|---|---|---|---|
| KNSAKINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | 1,582,635 | $31.3M | 1.08% |
| BBIOBRIDGEBIO PHARMA INC | COM | 1,023,950 | $28.1M | 0.97% |
| GEVGE VERNOVA INC COM | Stock | 7,826 | $2.57M | 0.09% |
| TTTRANE TECHNOLOGIES PLC | SHS | 2,338 | $863.54K | 0.03% |
| DADA NEXUS LTD23344D108 | ADS | 700,000 | $847K | 0.03% |
| PYXSPYXIS ONCOLOGY INC | COMMON STOCK | 382,606 | $596.87K | 0.02% |
| MOMOHELLO GROUP INC | ADS | 53,590 | $413.18K | 0.01% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 35 | $832.07M | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 38 | $1.67B | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 33 | $3.1B | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 33 | $4.09B | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 36 | $3.1B | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 49 | $3.54B | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 45 | $2.89B | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 48 | $4.56B | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 78 | $4.05B | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 63 | $4.6B | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 49 | $4.96B | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 60 | $4.48B | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 60 | $4.7B | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 70 | $5.64B | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 67 | $4.74B | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 61 | $3.8B | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 64 | $4.67B | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 64 | $4.79B | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 76 | $6.47B | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 85 | $7.65B | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 89 | $9.71B | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 91 | $10.12B | – | SEC |